2026 ISPE Facilities of the Future Conference

As facility design, manufacturing platforms, and digital systems continue to leap forward, regulators expect quality to keep up. At the 2026 ISPE Facilities of the Future Conference, the brand-new Compliance and Quality track puts that focus front and center.

Pharma companies are currently experiencing unprecedented challenges as a result of external factors such as geopolitics, the adoption of new modalities, rapidly changing technologies including digital ones, and also regulatory changes. In order to overcome these challenges, the pharmaceutical industry must accelerate and embrace new technologies, approaches and thinking. Hence to grow and prosper, the pharma industry needs to innovate faster, design and build quicker, and provide greater flexibility, whilst at the same time focusing on a quality first approach. One of the industry’s greatest challenges is determining how to adopt new technologies and approaches in the most effective and efficient manner. The 2026 ISPE Facilities of the Future Conference directly addresses these issues, equipping delegates with practical knowledge, expert insights, and clear guidance to help them navigate change and make informed decisions about future strategies.

The 2026 ISPE Facilities of the Future Conference is set to take place 2–3 February in San Diego, California, USA. The conference will focus on the future of pharmaceutical manufacturing, with dedicated technical tracks on compliance and quality; digital transformation, AI integration, and the future workforce; and innovative manufacturing and sustainability. In the blog post that follows, Grace Mineo, ISPE Emerging Leader Committee Member and Project Engineer at Takeda, shares what attendees can look forward to at this year’s event.

In the biopharmaceutical industry, the world is changing faster than buildings can be built. Companies are being asked to deliver breakthrough therapies, expand capacity, diversify modality pipelines, decarbonize operations, meet ever-shifting regulatory expectations, and stay globally competitive—all while maintaining reliability, safety, and cost control.

The pharmaceutical industry is entering a period of unprecedented complexity, where the speed of technological advancement, rising sustainability pressures, and expanding global demand require companies to rethink how they design, validate, and operate their manufacturing networks. The 2026 ISPE Facilities of the Future Conference brings these issues to the forefront, offering a forward-looking view into the tools, strategies, and innovations shaping tomorrow’s facilities, and the workforce needed to run them.

Mike Martin, President and CEO of ISPE, recently connected with Nicholas Capman, President and CEO of The FDA Group, a podcast that discusses current regulatory complexities facing the life science industry and explore innovative ways to overcome those challenges.

Explore three insightful sessions on the future of pharmaceutical facilities from thought leaders who presented at the 2025 Facilities of the Future Conference: “A New Standard for Designing Agile Manufacturing Facilities,” “Executive Forum Dinner and Panel Discussion,” and “Lilly’s Manufacturing Innovation to Reach More Patients.” These videos feature expert perspectives on flexible design, the current state and future direction of facilities of the future, and innovative strategies to enhance patient access. Watch now to gain valuable insights ahead of the 2026 ISPE Facilities of the Future Conference, taking place 2–3 February in San Diego, California, USA, and virtually.